Axitinib (Inlyta)

Indications

  • Breast Cancer (see Breast Cancer, [[Breast Cancer]])
  • Renal Cell Carcinoma (see Renal Cancer, [[Renal Cancer]]): FDA-approved

Pharmacology

  • Tyrosine Kinase Inhibitor

Metabolism

  • xxxx

Administration

  • xxxx

Dose Adjustment

  • Hepatic:
  • Renal:

Adverse Effects

Dermatologic Adverse Effects

  • Chemotherapy-Induced Acral Erythema (Hand-Foot Syndrome, Palmar-Plantar Erythrodysesthesia) (see Chemotherapy-Induced Acral Erythema, [[Chemotherapy-Induced Acral Erythema]])

Other Adverse Effects

  • xxx
  • xxx
  • xxx

References

  • xxxx